TY - JOUR T1 - A longitudinal PRINTO study on growth and puberty in juvenile systemic lupus erythematosus JF - Annals of the Rheumatic Diseases JO - Ann Rheum Dis SP - 511 LP - 517 DO - 10.1136/annrheumdis-2011-200106 VL - 71 IS - 4 AU - Marite Rygg AU - Angela Pistorio AU - Angelo Ravelli AU - Mohamad Maghnie AU - Natascia Di Iorgi AU - Brigitte Bader-Meunier AU - Carlos Da Silva AU - Rosa Roldan-Molina AU - Judith Barash AU - Cristina Dracou AU - Sylvie Gandon Laloum AU - Katerina Jarosova AU - Chantal Job Deslandre AU - Isabelle Koné-Paut AU - Franco Garofalo AU - Joseph Press AU - Claudia Sengler AU - Tsivia Tauber AU - Alberto Martini AU - Nicolino Ruperto Y1 - 2012/04/01 UR - http://ard.bmj.com/content/71/4/511.abstract N2 - Objective To obtain longitudinal data on growth/puberty in a large-scale, multi-national prospective cohort of juvenile systemic lupus erythematosus (SLE). Methods Data from 331/557 (59.4%) patients ≤18 years old with juvenile SLE in active phase, with anthropometric data available at four follow-up visits, were studied. Results There was a significant reduction in parent-adjusted height z score with time in females and males (p<0.0001), with a significant gender difference (p<0.0001) and with male height being most affected. Median body mass index z score peaked at 6 months and was still significantly above baseline after 26 months (p<0.01), with no gender difference. Standardised height reduction was inversely related to age at onset. Females with onset age <12 years had a median parent-adjusted height z score of −0.87 with no catch-up growth. At the end of the study, growth failure was seen in 14.7% of the females and 24.5% of the males. Height deflection (less than −0.25/year) was found in 20.7% of the females and 45.5% of the males. Delayed pubertal onset was seen in 15.3% and 24% of the females and males, respectively, and delayed/absent menarche was seen in 21.9%, while 36.1% of the females and 44% of the males had some degree of delayed pubertal development. Growth failure baseline determinants were previous growth failure (OR: 56.6), age at first visit ≤13.4 years (OR: 4.2) and cumulative steroid dose >426 mg/kg (OR: 3.6). Conclusions The children at risk of having a negative effect on height and pubertal development are prepubertal and peripubertal children treated with >400 mg/kg cumulative dose of corticosteroids. ER -